GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) » Definitions » Ending Cash Position

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Ending Cash Position : Rp1,177,092 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Ending Cash Position?

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Ending Cash Position for the quarter that ended in Mar. 2025 was Rp1,177,092 Mil.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's quarterly Ending Cash Position declined from Sep. 2024 (Rp978,232 Mil) to Dec. 2024 (Rp855,569 Mil) but then increased from Dec. 2024 (Rp855,569 Mil) to Mar. 2025 (Rp1,177,092 Mil).

PT Industri Jamu dan Farmasi Sido Muncul Tbk's annual Ending Cash Position declined from Dec. 2022 (Rp923,047 Mil) to Dec. 2023 (Rp830,128 Mil) but then increased from Dec. 2023 (Rp830,128 Mil) to Dec. 2024 (Rp855,569 Mil).


PT Industri Jamu dan Farmasi Sido Muncul Tbk Ending Cash Position Historical Data

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Ending Cash Position Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,031,954.00 1,082,219.00 923,047.00 830,128.00 855,569.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,101,632.00 719,779.00 978,232.00 855,569.00 1,177,092.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=830128+25441
=855,569

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=855569+321523
=1,177,092


PT Industri Jamu dan Farmasi Sido Muncul Tbk Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Gajahmada No. 123, 1st Floor, Gedung Hotel Tentrem, Office Sido Muncul, Lantai 1, Semarang, IDN, 50134
PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine and supplement, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Headlines

No Headlines